IFIT2 and COVID-19: IFIT1, IFIT2 and IFIT3 have been shown to be upregulated in cells infected with SARS-CoV-2, indicating activation of the interferon innate response, which could be regarded as potential drug targets for the treatment of COVID-19 (46–48).